People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocucure Therapeutics Inc | — | Pharmaceuticals | Pre-Seed | $1.8M | $4.7M | 2015 |
Paul H. Willams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul H. Willams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| W. Ben Deibler | 1 | 1 |
| Richard M. Haugen | 1 | 1 |
| Harry S. Davis | 1 | 1 |
| Sunder H. Malkani | 1 | 1 |
| Paul S. Williams | 1 | 1 |
| Steve M. Martin | 1 | 1 |
| Harry F. Davis | 1 | 1 |
| Rick H. Haugen | 1 | 1 |
| Ben H. Deibler | 1 | 1 |
| Steve H. Martin | 1 | 1 |
| Harry H. Davis | 1 | 1 |
| George H. Harvey, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.